James O Armitage
Overview
Explore the profile of James O Armitage including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
248
Citations
10596
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Roschewski M, Longo D, Armitage J
JAMA Oncol
. 2025 Feb;
PMID: 39913153
Importance: Achieving remission is the first step toward a cure in treating aggressive B-cell lymphomas. Radiographic imaging, such as fluorodeoxyglucose-positron emission tomography/computed tomography scans are the current standard to define...
2.
Armitage J, Longo D
N Engl J Med
. 2024 Oct;
391(15):1452-1454.
PMID: 39413381
No abstract available.
3.
4.
Vose J, Fu K, Wang L, Mansoor A, Stewart D, Cheng H, et al.
J Hematol Oncol
. 2023 Dec;
16(1):122.
PMID: 38104096
Background: Patients with mantle cell lymphoma (MCL) exhibit a wide variation in clinical presentation and outcome. However, the commonly used prognostic models are outdated and inadequate to address the needs...
5.
Bhatt V, Wichman C, Koll T, Fisher A, Wildes T, Berger A, et al.
J Geriatr Oncol
. 2023 Nov;
15(1):101676.
PMID: 38000343
Introduction: Many older adults with acute myeloid leukemia (AML) do not receive chemotherapy because of physicians' and patients' concern for toxicities and functional decline. This highlights the critical and urgent...
6.
Gromowsky M, DAngelo C, Lunning M, Armitage J
Fac Rev
. 2023 Sep;
12:21.
PMID: 37655119
ALK-positive anaplastic large cell lymphoma (ALCL) represents approximately 6-7% of the mature T-cell lymphomas. This subtype contains a translocation between the ALK gene on chromosome 2 and one of several...
7.
Bennett C, Georgantopoulos P, Gale R, Knopf K, Hrushesky W, Nabhan C, et al.
Expert Opin Drug Saf
. 2023 Aug;
22(9):783-788.
PMID: 37594915
Introduction: Nuclear reactor incidents and bioterrorism outbreaks are concerning public health disasters. Little is known about US Food and Drug Administration (FDA)-approved agents that can mitigate consequences of these events....
8.
Vose J, Ganguly S, Bierman P, Bociek R, Lunning M, Lyden L, et al.
Br J Haematol
. 2023 Apr;
202(1):116-121.
PMID: 37096954
Improved maintenance treatments are needed for patients with relapsed/refractory aggressive lymphomas after autologous haematopoietic stem cell transplantation (ASCT). Several studies with lenalidomide have been found to have activity in the...
9.
Liu C, Baine M, Fisher K, Armitage J, Enke C
Clin Lymphoma Myeloma Leuk
. 2022 Dec;
23(2):e125-e129.
PMID: 36572584
No abstract available.
10.